11
0
0
Like?
Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Brrr…It’s Cold! Can Blood Nanovesicles Encourage Heat Production and Help Fight Obesity?
Exosomes are cell derived nanovesicles found in all body fluids that mediate intercellular communication...
Can personalized medicine subtype bladder cancer?
Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...
Can a rabies vaccination booster save African Wild Dogs?
Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...